Delivery of endostatin in experimental cancer therapy

被引：0
|
作者：
Sorensen, DR [1 ]
Read, TA
机构：
[1] Univ Oslo, Rikshosp, Dept Comparat Med, N-0027 Oslo, Norway
[2] Univ Bergen, Dept Anat & Cell Biol, N-5020 Bergen, Norway
来源：
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY | 2002年 / 83卷 / 06期
关键词：
cancer; delivery; endostatin;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Endostatin, the 20 kDa C-terminal fragment of collagen XVIII, has been shown to be an effective inhibitor of tumour angiogenesis and growth in different experimental systems and is currently in Phase II/III clinical trials. One challenging aspect of anti-angiogenic treatment is the mode of delivery of the active compound. In this paper we review some of the basic knowledge of endostatin and look specifically into the different possible ways in which endostatin may be administered.
引用
收藏
页码：265 / 274
页数：10
相关论文
共 50 条
  • [21] Optimizing drug delivery for enhancing therapeutic efficacy of recombinant human endostatin in cancer treatment
    Xu, Fuguo
    Ma, Qingyong
    Sha, Huanchen
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2007, 24 (05): : 445 - 492
  • [22] Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer
    Qiu, Bo
    Ji, Minghui
    Song, Xiaosong
    Zhu, Yongqiang
    Wang, Zhongyuan
    Zhang, Xudong
    Wu, Shu
    Chen, Hongbo
    Mei, Lin
    Zheng, Yi
    NANOSCALE RESEARCH LETTERS, 2012, 7 : 1 - 11
  • [23] Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer
    Bo Qiu
    Minghui Ji
    Xiaosong Song
    Yongqiang Zhu
    Zhongyuan Wang
    Xudong Zhang
    Shu Wu
    Hongbo Chen
    Lin Mei
    Yi Zheng
    Nanoscale Research Letters, 7
  • [24] Endostatin: The logic of antiangiogenic therapy
    Abdollahi, A
    Hlatky, L
    Huber, PE
    DRUG RESISTANCE UPDATES, 2005, 8 (1-2) : 59 - 74
  • [25] Oligonucleotide delivery in cancer therapy
    De Rosa, Giuseppe
    De Stefano, Daniela
    Galeone, Aldo
    EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (11) : 1263 - 1278
  • [26] Gene Delivery for Cancer Therapy
    Zhang, Teng
    CURRENT DRUG DELIVERY, 2014, 11 (02) : 233 - 242
  • [27] Gene Therapy with the Angiogenesis Inhibitor Endostatin in an Orthotopic Lung Cancer Murine Model
    Ning, Tao
    Yan, Xi
    Lu, Ze-Jun
    Wang, Guo-Ping
    Zhang, Ning-Gang
    Yang, Jin-Liang
    Jiang, Sha-Sha
    Wu, Yang
    Yang, Li
    Guan, Yong-Song
    Luo, Feng
    HUMAN GENE THERAPY, 2009, 20 (02) : 103 - 111
  • [28] Intravenous cationic liposome endostatin gene therapy for spontaneous canine cancer.
    MacEwen, EG
    Thamm, DH
    Medberry, P
    Elmslie, RE
    Dow, SW
    CLINICAL CANCER RESEARCH, 1999, 5 : 3811S - 3812S
  • [29] Radiosensitization of breast cancer cells by TRAIL-endostatin-targeting gene therapy
    Li, Y. B.
    Guo, C. X.
    Wang, Z. C.
    Dong, L. H.
    Guan, F.
    Liu, Y.
    Wang, H. F.
    Sun, Z. W.
    Gong, S. L.
    NEOPLASMA, 2013, 60 (06) : 613 - 619
  • [30] EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV
    K S Balaggan
    K Binley
    M Esapa
    R E MacLaren
    S Iqball
    Y Duran
    R A Pearson
    O Kan
    S E Barker
    A J Smith
    J W B Bainbridge
    S Naylor
    R R Ali
    Gene Therapy, 2006, 13 : 1153 - 1165
12345